Effect of organizational change on employee innovation performance: A dual mediation model. [PDF]
Liu T +7 more
europepmc +1 more source
ABSTRACT Objective To determine whether integration of serum neurofilament light chain (NfL) and cortical dysfunction improves diagnostic accuracy in amyotrophic lateral sclerosis (ALS) when applied alongside the Gold Coast criteria (GCC). Methods In this prospective study, 148 participants with suspected ALS were recruited (101 ALS and 47 with ALS ...
Aicee Dawn Calma +16 more
wiley +1 more source
The Determinants of Innovation Resistance and Innovation Performances
Byeong Deok Ahn, Kwan Young Ahn
openaire +2 more sources
The impact of patent infringement litigation decisions on firms' innovation performance in China. [PDF]
Deng Y, Qi Y, Guo Q.
europepmc +1 more source
ABSTRACT Objective Early risk stratification may support clinical decision‐making in spontaneous intracerebral hemorrhage (ICH). We aimed to develop and internally validate HAGIV, a score integrating frequency of imaging markers (FIM), a time‐adjusted non‐contrast computed tomography (CT) metric of hematoma expansion, with established predictors for 90‐
Lei Song +10 more
wiley +1 more source
Applications of artificial intelligence and urban innovation performance: A quasi-natural experiment based on the pilot zones for the innovative application of artificial intelligence. [PDF]
Han S, Sun X, Zhong S.
europepmc +1 more source
The Multiple Sclerosis Severity Allele rs10191329A and Cognitive Function: A UK Biobank Study
ABSTRACT The genome‐wide association study of Multiple Sclerosis severity linked the genetic variant rs10191329A to long‐term disability and implicated brain resilience as a determinant of outcome. We hypothesised that rs10191329A might influence cognition in other neurological diseases and healthy controls.
Ioanna Zimianiti +5 more
wiley +1 more source
Correction: Corporate internal control, financial mismatch mitigation and innovation performance. [PDF]
Li X, Zhao Z.
europepmc +1 more source
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang +23 more
wiley +1 more source
Who is in the driving seat? Assessing innovation performance feedback and digital transformation of manufacturing enterprises. [PDF]
Li D +4 more
europepmc +1 more source

